Scancell progresses its new anti-glycan monoclonal antibody (mAb) platform GlyMab™ To download click here Thursday 17 March 2022 17:08 Categories: GlyMab Year - 2022
Update on COVIDITY Phase 1 clinical trial in South Africa To download click here Monday 31 January 2022 14:16 Categories: Covid-19 News Regulatory News Year - 2022
Interim Results for the 6 months ended 31 October 2021 To download click here Wednesday 26 January 2022 08:57 Categories: News Regulatory News Year - 2022
Results of AGM 2021 To download click here Wednesday 24 November 2021 13:43 Categories: News Regulatory News
Introducing Scancell's New Facilities Wednesday 24 November 2021 13:01 Categories: Media Coverage News Year - 2021
AGM Presentation 2021 To download click here Wednesday 24 November 2021 07:01 Categories: Presentations Year - 2021
First patient dosed in SCIB1 Phase 2 clinical trial To download click here Friday 19 November 2021 08:20 Categories: News Regulatory News SCIB1 Year - 2021
Scancell Results for the year ended 30 April 2021 To download click here Friday 29 October 2021 08:03 Categories: News Year - 2021
Extension of Convertible Loan Note Redemption Dates To download click here Thursday 28 October 2021 08:51 Categories: News Regulatory News Year - 2021
Scancell expands its R&D capabilities with new facilities at The Oxford Science Park To download click here Wednesday 20 October 2021 15:39 Categories: News Year - 2021